Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072617 · ClinicalTrials.gov registry record · NA
Cerebellar rTMS for the Treatment of Schizophrenic Patients
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01072617: Completed NA study, sponsored by Beth Israel Deaconess Medical Center.
NCT01072617 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01072617, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The primary aim of this protocol is to determine whether the use of repetitive transcranial magnetic stimulation (rTMS) over vermis of the cerebellum may be safe and therapeutically effective in patients with schizophrenia. Because this is the first evaluation of this treatment in this population, the focus of this study is safety.
Primary Outcome
Adverse event collection at baseline, daily for 5 days during treatment, every other day by phone until the final assessment at week 1 follow up visit.
Interventions
- DEVICE Transcranial magnetic stimulation via MagPro x100 device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-04 |
| Phase | NA |
What the finished NCT01072617 record still lists
NCT01072617 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Transcranial magnetic stimulation via MagPro x100 device is the first listed.
NCT01072617 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01072617 about?
NCT01072617 is a clinical study titled "Cerebellar rTMS for the Treatment of Schizophrenic Patients". The primary aim of this protocol is to determine whether the use of repetitive transcranial magnetic stimulation (rTMS) over vermis of the cerebellum may be safe and therapeutically effective in patients with schizophrenia. Because this is the first evaluation of this treatment in this population, t...
What is the current status of trial NCT01072617?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2008-02. Estimated completion is 2009-04.
What interventions are being tested in trial NCT01072617?
The interventions under investigation include: Transcranial magnetic stimulation via MagPro x100 device (DEVICE).
Who is sponsoring clinical trial NCT01072617?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01072617's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia